Molecular characterization of patients with pathologic complete response or early failure after neoadjuvant chemotherapy for locally advanced breast cancer using next generation sequencing and nCounter assay

Neoadjuvant chemotherapy (NAC) has the added advantage of increasing breast conservation rates with equivalent survival outcomes compared with adjuvant chemotherapy. A subset of breast cancer patients who received NAC experienced early failure (EF) during the course of therapy or within a short peri...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Oncotarget
Główni autorzy: Park, Kyunghee, Choi, Moon Ki, Jung, Hae Hyun, Do, In-Gu, Lee, Kwang Hee, Ahn, TaeJin, Kil, Won Ho, Kim, Seok Won, Lee, Jeong Eon, Nam, Seok Jin, Kim, Duk-Hwan, Ahn, Jin Seok, Im, Young-Hyuck, Park, Yeon Hee
Format: Artigo
Język:Inglês
Wydane: Impact Journals LLC 2015
Hasła przedmiotowe:
Clinical Research Paper
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4695201/
https://ncbi.nlm.nih.gov/pubmed/26009992
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy